nūhou

ʻO kahi loiloi hou i paʻi ʻia e kahi hui noiʻi ʻepekema ʻo Kanada e hōʻike ana e hiki i nā cannabinoids ke hana i kahi hana i ka pale ʻana a me ka mālama ʻana i ka COVID-19 a me ka COVID lōʻihi.

Ma kahi loiloi piha, hāʻawi kahi pūʻulu o nā ʻepekema Kanada i nā ʻike hoihoi i ke kuleana o ka cannabinoids i ka hakakā ʻana i ka maʻi COVID-19.ʻO ke aʻo ʻana, i kapa ʻia ʻo "Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 and Chronic COVID-19 Patients," i kākau ʻia e Cassidy Scott, Stefan Hall, Juan Zhou, Christian Lehmann a me nā mea ʻē aʻe a paʻi ʻia ma ka Journal of SARS-CoV -2 ″ makasina.

Laau lapaau.Ma ka nānā ʻana i ka ʻikepili nui mai nā noiʻi i hala, e kūkākūkā ka hōʻike pehea e hiki ai i nā ʻāpana o ka lāʻau cannabis ke hana nui i ka pale ʻana i ka hoʻomaka ʻana o COVID-19 a me ka hoʻēmi ʻana i kona hopena lōʻihi.Hōʻike nā ʻike e hiki i nā cannabinoids, ʻoi aku ka mea i unuhi ʻia mai ka lāʻau cannabis, hiki ke kāohi i ka komo ʻana o nā maʻi i loko o nā cell, e hōʻemi i ke koʻikoʻi oxidative pōʻino, a hoʻopaʻa i ka pane kūlohelohe pinepine i ʻike ʻia i nā hihia koʻikoʻi.Hōʻike ka haʻawina i ka hiki ke hana o nā cannabinoids i ka hoʻoponopono ʻana i nā hōʻailona like ʻole o ka COVID-19 lōʻihi.

Wahi a ke aʻo ʻana, hiki i nā cannabinoids ke pale i ke komo ʻana o ka maʻi viral, hoʻēmi i ke kaumaha oxidative a me ka hoʻēmi ʻana i ka ʻino cytokine e pili ana i ka maʻi COVID-19.Hōʻike ka noiʻi i kēlā kikoʻīcannabinoid extractshiki ke hoʻohaʻahaʻa i nā pae o ka angiotensin-converting enzyme 2 (ACE2) i loko o nā ʻiʻo koʻikoʻi, ma laila e pale ai i nā maʻi mai ke komo ʻana i nā sela kanaka.Hoʻomaopopo ka poʻe noiʻi he mea koʻikoʻi kēia i hāʻawi ʻia i ke kuleana o ACE2 ma ke ʻano he puka mua no ke komo ʻana i ka viral.Kūkākūkā pū ka hōʻike i ka hana o nā cannabinoids i ka hoʻoponopono ʻana i ke kaumaha oxidative, kahi mea nui i ka pathogenesis o COVID-19.

Ma ka hoʻololi ʻana i nā radical manuahi i loko o nā ʻano reactive liʻiliʻi, nā cannabinoids e like meCBDhiki ke kōkua i ka hoʻēmi ʻana i nā hopena ʻino o ke kaumaha oxidative i nā hihia koʻikoʻi o COVID-19.Wahi a ke aʻo ʻana, hiki i nā cannabinoids ke loaʻa i nā hopena maikaʻi i nā ʻino cytokine, ka pane ʻana o ka pale kino i hoʻoiho ʻia e COVID-19.Ua hōʻike ʻia ʻo Cannabinoids i ka maikaʻi i ka hōʻemi ʻana i nā cytokine inflammatory, e hōʻike ana i ko lākou hiki ke hoʻokele i nā pane kūlohelohe.

ʻO ka lōʻihi COVID e pili ana i ke ʻano maʻamau e like me ka hoʻololi ʻana o COVID-19 i ka pae maʻi.Hōʻike ka noiʻi i ka hiki o nā cannabinoids i ka mālama ʻana i nā hōʻailona mau o ke kaumaha, hopohopo, post-traumatic stress disorder, insomnia, ʻeha a me ka nele o ka makemake.He kuleana ko ka ʻōnaehana endocannabinoid i ka launa pū ʻana o nā ʻōnaehana nerve like ʻole, e hoʻolilo iā ia i pahuhopu no ka mālama ʻana i kēia mau hōʻailona neuropsychiatric.

Ua ʻimi pū ka noiʻi ʻana i nā ʻano ʻai like ʻole a me nā ʻano huahana cannabis i hoʻohana ʻia e nā mea kūʻai.Hōʻike ka noiʻi i ka ʻai ʻana ma o ka inhalation hiki ke loaʻa nā hopena maikaʻi ʻole i ka poʻe me nā maʻi hanu, e kūʻē ana i kona hopena therapeutic."ʻOiai ʻo ka puhi ʻana a me ka vaping ka mea i makemake ʻia no ka poʻe maʻi cannabis no ka mea ʻoi aku ka wikiwiki o ka hana, hiki ke hoʻopau ʻia nā pōmaikaʻi o ka cannabinoid therapy e nā hopena maikaʻi ʻole o ka inhalation i ke olakino hanu," wahi a nā mea noiʻi.Hōʻike Hōʻikeʻike "ʻO nā maʻi e hoʻohana ana i ka cannabis vaporization ka liʻiliʻi o nā hōʻailona hanu ma mua o ka puhi ʻana no ka mea ʻaʻole wela ka mea vaporizer i ka cannabis a hiki i ka wela."ʻO ka manaʻo o nā mea kākau o ka hōʻike i ka pono e noiʻi hou aku ma kēia wahi.ʻOiai ke paipai nei nā ʻike mua, ʻōlelo lākou he mea mua lākou a kumu mai nā haʻawina ʻaʻole kikoʻī iā COVID-19.No laila, ʻoi aku ka nui o nā haʻawina i manaʻo ʻia a piha hoʻi, me nā hoʻokolohua lapaʻau, he mea koʻikoʻi e hoʻomaopopo piha i ka hana a me ka pono o nā cannabinoids i ka mālama ʻana i ka maʻi mua a me ka maʻi maʻi SARS-CoV-2.Eia kekahi, ke kākoʻo nei nā mea kākau no ka noiʻi hohonu hou ʻana i ka lāʻau lapaʻau a me nā noi therapeutic kūpono o ka ʻōnaehana endocannabinoid a koi aku i ke kaiāulu ʻepekema e ʻimi ikaika i kēia ala.